ShadowBuys

Genmab A/S (GMAB)

Healthcare · Biotechnology

4 members of Congress have disclosed 13 trades in Genmab A/S (GMAB) since 2020: 8 buys and 5 sales. The most recent was disclosed on Jul 21, 2026. 1 trade was made by members of a committee that oversees Genmab A/S's industry.

Trades disclosed
13
Members trading
4
Buys / sells
8 / 5
Reported value
$62K–$280K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow GMAB

What else is happening at GMAB

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.

Committee overlaps

Trades by members of a committee that oversees Genmab A/S's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded GMAB

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.